Home fetal doppler devices were banned from sale in Australia last year but they are still readily available for purchase ...

SAN DIEGO -- Frequent fetal heart monitoring is not needed in every pregnant woman testing positive for anti-SSA/anti-Ro autoantibodies, but it's definitely advisable for those with high titers, ...

Please provide your email address to receive an email when new articles are posted on . Heart rate monitoring may be a crucial means of detecting rhythm abnormalities in the fetuses of pregnant ...

SAN DIEGO, California — Pregnant women with anti-SSA/Ro autoantibodies at titer levels of less than 1000 ELISA units per mL are at minimal to no risk for fetal atrioventricular (AV) block and may be ...

Some 99% of global newborn deaths occur in low- and middle-income countries (LMICs), where pregnant women often struggle to access adequate fetal monitoring. In Tanzania, with 24 neonatal deaths per 1 ...

April 6 (UPI) --Basic fetal heartbeat monitoring is still the best method for determining whether a baby is in distress and Caesarean delivery is needed, according to an analysis published Monday by ...

A new type of fetal heart monitor could save the lives of unborn infants in complicated pregnancies, according to a study published in the International Journal of Engineering Systems Modelling and ...

The Meridian M100 and M110 Fetal Heart Monitors 6 are intended to be compatible with qualified fetal monitoring systems, facilitating rapid adoption by clinicians where MERIDIAN is commercially ...

EFM can monitor the baby’s health during labor by continuously recording the fetal heart rate. The fetal heart rate pattern is important to assess because it can help determine if the fetus is getting ...

A group of Polish doctors and scientists have developed a portable fetal heart monitor which allows for examinations to be performed remotely, with data sent to doctors and nurses. Patrycja ...

Feb. 6, 2003 — Electronic fetal monitoring does not improve outcome, according to the results of a prospective, randomized trial reported in the Feb. 8 issue of The Lancet. "The findings of this trial ...